This survey is conducted for preparing application material for re-examination under the
Pharmaceutical Affairs Law and its Enforcement Regulation; its aim is to reconfirm the
clinical usefulness of COZAAR XQ through collecting the safety and efficacy information
according to the Re-examination Regulation for New Drugs.